Episode Details

Shadd Dales and Anthony Varrell welcome back cannabis advisor and investor Seth Yakatan to break down a pivotal moment in the cannabis industry.We’ve officially entered what many are calling the “survivor period” in marijuana, where fundamentals are coming to the forefront. The era of easy money is over, and only well-positioned cannabis operators will remain standing. With capital tightening and valuations resetting, the smart money could see this as a key investment opportunity.Seth shares why the long-anticipated wave of consolidation hasn’t fully materialized in the cannabis space, pointing to financial constraints, overleveraged operators, and lack of clarity on rescheduling cannabis at the federal level. As we enter a critical 18-month window, the question is: who will consolidate, and who will be left behind?We also dive into the rise of cannabis beverages, as companies like Curaleaf pivot into hemp-derived products. Is this a smart strategic move—or a risk?Lastly, the AFC Gamma lawsuit signals deeper financial strain across the marijuana industry, with implications for lenders, operators, and investors.0:00:00 - Intro0:01:02 - Seth's activities and conference circuit0:02:40 - Survivor syndrome in cannabis industry0:11:31 - Investment strategies & top-performing companies0:20:43 - Beverage market and CuraLeaf's strategic moves0:26:42 - Recent earnings season highlights0:31:01 - Market saturation and retail licensing0:33:30 - Beverage market potential and future acquisitions0:35:14 - Potential impact of rescheduling on the cannabis industry0:38:20 - Closing remarks and future outlook#Cannabis #CannabisIndustry #CannabisStocks #Marijuana #CannabisInvestment #ReschedulingCannabis #CannabisNews #SmartMoney #HempBeverages #CannabisBusiness

Listen Now